Rise and shine, everyone, another busy day is on the way. And it is also a frigid on here on the Pharmalot campus, where the shortest person is staying home to nurse an illness and the official mascots are looking for a cozy spot to snooze. As for us, we are keeping warm by — you guessed it — quaffing cups of stimulation. As always, you are invited to join us, because no prescription is required. Meanwhile, here are the usual tidbits. Hope you have a lovely day and accomplish great things. Keep in touch …

GlaxoSmithKline says that two major clinical studies successfully tested a new two-drug treatment regimen to control the virus that causes AIDS, Reuters tells us. The results are a boost for its ViiV Healthcare venture, because the approach is a departure from conventional triple drug cocktails that can cause troublesome side effects, especially among older patients who make up a growing proportion of those treated for the disease.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • “Do you have questions about your prescription? Ask the pharmacist.” The sign must be in both English and Spanish and no smaller than 8.5 inches by 11 inches. The sign must be posted in clear public view at all locations where a patient may pick up prescriptions.”

    The above is what passes for pharmacy counseling in at least one state. What’s really scary is, and I’ve heard this personally, is when pharmacists go beyond the limits of their knowledge and start dispensing medical advice. Hey, what the heck, it’s free and there is no waiting around for the doctor to see you. Unless you are unlucky enough to come across that pharmacist mentioned on the blog who practices in Sevierville, TN, ground zero for heroin addiction country, who didn’t know what naloxone was.

Comments are closed.

Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy